evoke semaglutide trial EVOKE/EVOKE+ Results of EVOKE and EVOKE+

Experts note that every pregnancy starts with a 3-5% baseline chance of birth defects regardless of medication exposure

Current neuropharmacology, 12(2), 140147

Grigsons comment here about stress is particularly intriguing so much of the conversation around addiction centers on the co-occurrence and precipitators of psychological stress, anxiety, and depression

Nrf2 likely confers a growth advantage to cancer cells through enhancing cytoprotection and anabolism

Cellular assays have enabled detailed examination of second messenger dynamics, such as cyclic AMP generation and calcium mobilization, while animal models have provided insight into systemic signal coordination and feedback regulation along the hypothalamic pituitary axis